Sidley Austin advised Synchrony Financial, and Davis Polk advised the joint book-running managers. Synchrony Financial announced an SEC-registered offering of $750 million aggregate principal amount of...
Synchrony Financial’s $750 Million Subordinated Notes Offering
Emergent Cold Latin America’s Acquisition of Qualianz
44 Capital Finanças Corporativas acted as financial advisor to Emergent Cold LatAm. Latham & Watkins LLP and Creel, García-Cuéllar, Aiza y Enríquez acted as legal advisors...
China Fortune Land Development Co. Ltd.’s $4.96 Billion Offshore Debt Restructuring
Appleby and Sidley Austin acted as counsels to China Fortune Land Development Co. Ltd. on the restructuring by way of English scheme of arrangement. The complex...
Faraday Future Intelligent Electric’s $135 Million Financing Agreement
Sidley advised Faraday Future Intelligent Electric Inc. on the deal. Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or “Company”), a California-based global shared...
Regal Rexnord Corporation’s $4.7 Billion Senior Notes Offering
Sidley represented Regal Rexnord, and Simpson Thacher represented the initial purchasers. Regal Rexnord Corporation (NYSE: RRX) announced a 144A/Regulation S offering consisting of four tranches of...
DraftKings’ Victory in a Securities Class Action Suit
Sullivan & Cromwell advised DraftKings on the deal. DraftKings obtained the dismissal of putative securities class action arising from its acquisition of gaming-technology company SBTech. The...
Denali’s US$236 Million Business Combination With Longevity Biomedical
Sidley advised Denali Capital Acquisition Corp., while Nelson Mullins Riley & Scarborough LLP assisted Longevity Biomedical. US Tiger Securities acted as business combination advisor to Denali. Denali...
ADARx Pharmaceuticals’ US$46 Million Series B-1 Financing
Sidley represented ADARx Pharmaceuticals, Inc. on the deal. ADARx Pharmaceuticals, Inc., a clinical-stage biotechnology company developing RNA-targeting therapeutics, announced its US$46 million Series B-1 financing. The proceeds...
Sun Capital Partners’ Acquisition of Fresh Origins
Sidley represented Fresh Origins on the deal. Fresh Origins announced its sale to private equity firm Sun Capital Partners, Inc. Fresh Origins is a grower and shipper...
YH Entertainment’s HK$490 Million Initial Public Offering
Cooley advised YH Entertainment on the deal. Sidley acted as Hong Kong legal counsel for the joint sponsors and overall coordinators China Securities (International) Corporate Finance...
Crown Bioscience’s Acquisition of Indivumed’s CRO Services Business
Freshfields Bruckhaus Deringer advised Indivumed GmbH on the deal while Sidley is represented Crown Bioscience. Indivumed GmbH sold its “IndivuServ” business unit to a wholly owned...
Tricida’s Chapter 11 Liquidation
Sidley is advising Tricida, Davis Polk is advising convertible senior noteholders and the indenture trustee, and also Greenberg Traurig is advising the indenture trustee. On January...